<DOC>
	<DOC>NCT01039584</DOC>
	<brief_summary>This was a study that compared the efficacy and safety of a generic butoconazole nitrate vaginal cream, 2% to Gynazole-1 (butoconazole nitrate) Vaginal Cream, 2% in the treatment of vulvovaginal candidiasis caused by Candida species.</brief_summary>
	<brief_title>A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis, Vulvovaginal</mesh_term>
	<mesh_term>Butoconazole</mesh_term>
	<criteria>Female subjects, at least 18 years of age Presented with symptomatic vulvovaginitis consistent with a diagnosis of moniliasis Signed and dated informed consent Were pregnant, nursing, or planning a pregnancy within the study participation period Had evidence of any bacterial, viral, or protozoal infection Had hypersensitivity or allergy to the imidazoles, their analogues, and/or any of the Test Product ingredients Had any medical condition, or used any medication which, in the opinion of the investigator, could have interfered with the conduct of the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>butoconazole</keyword>
	<keyword>vulvovaginal</keyword>
	<keyword>candidiasis</keyword>
</DOC>